Data from the GEPIA 2 database [139] indicate that Gal-1 expression is significantly decreased in six tumor types, increased in ten, and shows no significant changes in another seventeen tumor types compared to normal samples (Fig. 5). This evidence concerns the gene GAL and neoplasm.